Chesapeake Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Chesapeake Asset Management's PFE Position: Q2 2026 in Review
Chesapeake Asset Management increased its Pfizer (PFE) stake by 0.91% in Q2 2026, buying an estimated $942 and bringing the position to 4,008 shares worth $96.5K. The position accounts for 0.07% of the portfolio, ranked #135.
Chesapeake Asset Management first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.04M in Q2 2016. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Chesapeake Asset Management held 4,008 shares of Pfizer worth $96.5K as of Q2 2026.
- Chesapeake Asset Management bought 36 Pfizer shares in Q2 2026, an estimated $942.
- Pfizer made up 0.07% of Chesapeake Asset Management's portfolio in Q2 2026, its #135 holding.
- Chesapeake Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
- Chesapeake Asset Management's Pfizer position peaked at $1.04M in Q2 2016.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.